Insider Selling: 111 (NASDAQ:YI) Director Sells 58,800 Shares of Stock

111, Inc. Sponsored ADR (NASDAQ:YI) Director Jian David Sun sold 58,800 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $0.23, for a total transaction of $13,524.00. Following the completion of the transaction, the director owned 413,211 shares in the company, valued at approximately $95,038.53. This represents a 12.46% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jian David Sun also recently made the following trade(s):

• On Thursday, June 11th, Jian David Sun sold 111,100 shares of 111 stock. The shares were sold at an average price of $0.23, for a total transaction of $25,553.00.
• On Wednesday, June 10th, Jian David Sun sold 115,440 shares of 111 stock. The shares were sold at an average price of $0.22, for a total transaction of $25,396.80.
• On Tuesday, June 9th, Jian David Sun sold 12,000 shares of 111 stock. The shares were sold at an average price of $0.23, for a total transaction of $2,760.00.
• On Wednesday, May 27th, Jian David Sun sold 70,440 shares of 111 stock. The shares were sold at an average price of $0.25, for a total transaction of $17,610.00.
• On Tuesday, May 26th, Jian David Sun sold 29,280 shares of 111 stock. The shares were sold at an average price of $0.27, for a total transaction of $7,905.60.

111 Stock Performance

111 stock opened at $4.57 on Tuesday. The firm has a market cap of $40.17 million, a PE ratio of -3.26 and a beta of 0.60. The firm’s 50 day moving average price is $5.88 and its two-hundred day moving average price is $5.66. 111, Inc. Sponsored ADR has a twelve month low of $2.48 and a twelve month high of $11.17.

Wall Street Analyst Weigh In

Separately, Weiss Ratings downgraded shares of 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, June 4th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

111 Company Profile

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.